摘要
口服悉复欢（环丙沙星）治疗呼吸道、泌尿道、消化道及其它急性细菌性感染患者３５例，临床总有效率为８８．６％，细菌清除率为８４．８％，不良反应发生率３／３５；与阳性对照药泰利必妥比较，试验药与对照药的临床总有效率、细菌清除率及不良反应发生率均无显著性差异。结果表明，悉复欢是一抗菌力强，抗菌谱广，疗效可靠，使用安全的抗菌药物。
In order to evaluate the theraputic efficacy and safety of oral cifran,a randomized controlled study was conducted on 35 patients with various bac-terial infections using Tarivid as control. The results of the study showed that no sta-tistically significant differences exist between Cifran and Tarivid in respect of total ef-fective rate, bacterial clearence rate and side-effect rate.
出处
《中国新药杂志》
CAS
CSCD
1995年第3期25-27,共3页
Chinese Journal of New Drugs
关键词
环丙沙星
悉复欢
细菌感染
Cipr Ofloxacin Ofloxacin Randomized controlled Clinical study
